مورد إلكتروني
Life-long antimicrobial therapy: Where is the evidence?.
| العنوان: | Life-long antimicrobial therapy: Where is the evidence?. |
|---|---|
| بيانات النشر: | Oxford University Press United Kingdom 2019-02-15 |
| تفاصيل مُضافة: | Lau J.S.Y. Korman T.M. Woolley I. |
| نوع الوثيقة: | Electronic Resource |
| مستخلص: | The decision to prescribe long-term or 'life-long' antibiotics in patients requires careful consideration by the treating clinician. While several guidelines exist to help assist in this decision, the long-term consequences are yet to be well studied. In this review, we aim to provide a summary of the available evidence for patient populations where long-term antibiotic therapy is currently recommended in clinical practice. We will also discuss the pitfalls of this approach, including medication adverse effects, economic cost and any possible contribution to the emerging epidemic of microbial resistance.Copyright © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. |
| مصطلحات الفهرس: | epidemic, graft infection/dt [Drug Therapy], heart arrest/si [Side Effect], human, infection prevention, inflammatory bowel disease/dt [Drug Therapy], long term care, microbiome, patient compliance, peripheral neuropathy/si [Side Effect], photosensitivity/si [Side Effect], Pneumocystis pneumonia/dt [Drug Therapy], prosthesis infection/dt [Drug Therapy], rheumatic fever/dt [Drug Therapy], splenectomy, tendinitis/si [Side Effect], urinary tract infection/dt [Drug Therapy], amoxicillin, antibiotic agent/ae [Adverse Drug Reaction], antibiotic agent/dt [Drug Therapy], antibiotic agent/pe [Pharmacoeconomics], azithromycin, benzathine penicillin, cefadroxil, cefalexin, ciprofloxacin, clarithromycin, clindamycin, cotrimoxazole, dicloxacillin, doxycycline, erythromycin, linezolid, lymecycline, metronidazole, minocycline, nitrofurantoin, norfloxacin, penicillin V, quinolone derivative, rifabutin, rifaximin, roxithromycin, sulfonamide, trimethoprim, voriconazole, cardiac implantable electronic device, heart arrhythmia/si [Side Effect], acne/dt [Drug Therapy], antibiotic prophylaxis, antibiotic resistance, antibiotic therapy, antimicrobial therapy, article, bacterial peritonitis/dt [Drug Therapy], cardiovascular mortality, chronic respiratory tract disease/dt [Drug Therapy], clinical practice, cystic fibrosis/dt [Drug Therapy], cytopenia/si [Side Effect], device infection/dt [Drug Therapy], drug cost, economic aspect, Article |
| URL: | Journal of Antimicrobial Chemotherapy LibKey Link |
| الإتاحة: | Open access content. Open access content Copyright 2019 Elsevier B.V., All rights reserved. |
| أرقام أخرى: | AUSHL oai:repository.monashhealth.org:1/36871 Journal of Antimicrobial Chemotherapy. 73 (10) (pp 2601-2612), 2018. Date of Publication: 2018. 0305-7453 https://repository.monashhealth.org/monashhealthjspui/handle/1/36871Test 29873746 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29873746Test] 626271156 (Lau, Korman, Woolley) Monash University, Clayton, VIC, Australia (Lau, Korman, Woolley) Monash Infectious Diseases, Monash Health, Clayton, VIC, Australia Lau J.S.Y.; jillian.lau@monash.edu 1305117436 |
| المصدر المساهم: | MONASH HEALTH LIBRS From OAIster®, provided by the OCLC Cooperative. |
| رقم الانضمام: | edsoai.on1305117436 |
| قاعدة البيانات: | OAIster |
| الوصف غير متاح. |